Regenxbio (RGNX) Other financing activities (2015 - 2025)

Regenxbio's Other financing activities history runs 11 years deep, the most recent figure standing at $90000.0 for Q4 2025.

• On a quarterly basis, Other financing activities rose 136.84% year-over-year to $90000.0 in Q4 2025; TTM through Dec 2025 was $318000.0, a 78.97% decrease from a year earlier, with the FY2025 full-year figure at $318000.0, down 78.97% from the prior year.
• Other financing activities climbed to $90000.0 in Q4 2025 per RGNX's latest filing, from $78000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $2.5 million in Q4 2021 and bottomed at $38000.0 in Q4 2024.
• The 5-year median for Other financing activities is $411000.0 (2024), against an average of $632941.2.
• Across the five-year window, Other financing activities tumbled 98.3% in 2022 and surged 1095.35% in 2023, its largest moves.
• Year by year, Other financing activities stood at $2.5 million in 2021, then tumbled by 98.3% to $43000.0 in 2022, then jumped by 1095.35% to $514000.0 in 2023, then plunged by 92.61% to $38000.0 in 2024, then soared by 136.84% to $90000.0 in 2025.
• Per Business Quant, the three latest RGNX Other financing activities figures stand at $90000.0 (Q4 2025), $78000.0 (Q2 2025), and $150000.0 (Q1 2025).